CYP2E1 and tuberculosis: As demonstrated in Table 5, GSTT1 null genotype was found to be significantly associated with a 2.99-fold increased risk of ATDILI in the TB patients who carried CYP2E1 wild type (adjusted OR = 2.99; 95% CI, 1.07 to 8.40; P = 0.037).